Sort
35,931 grants matching “parkinsons”
Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder
$774,788Michael J Howell · University Of Minnesota · R01 · FY2024 · AG
SPHERAMINE: A CELL-BASED THERAPY FOR PARKINSON'S DISEASE
$774,379Titan Pharmaceuticals, Inc. · R44 · FY2000 · NS
Administrative Core
$774,208Victor W. Henderson · Stanford University · P30 · FY2021 · AG
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts
$774,161Michael A Schwarzschild · Massachusetts General Hospital · U01 · FY2022 · NS
Innovating high-resolution novel imaging approaches to elucidate mechanisms of prion-like spreading of neurodegenerative disease
$774,092Jin Hyung Lee · Stanford University · R56 · FY2019 · AG
CORE--RELIGIOUS ORDERS STUDY
$773,112David A Bennett · Rush University Medical Center · P30 · FY2007 · AG
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$773,075David Dale Thomas · University Of Minnesota · R01 · FY2023 · HL
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$773,075David Dale Thomas · University Of Minnesota · R01 · FY2022 · HL
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
$772,770Xuemei Huang · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2019 · NS
Targeting Lewy Body Specific Pathology Using Biomarkers
$772,656Karen S Marder · Columbia University Health Sciences · U01 · FY2016 · NS
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
$772,542Michael D Fox · Brigham And Women'S Hospital · R01 · FY2022 · MH
Tau Conformation in Tauopathies and Neuronal Function
$772,520Scott Thomas Brady · University Of Illinois At Chicago · R01 · FY2023 · NS
Identifying Regulators of Degeneration due to Defective Mitochondrial DNA
$772,432Ming Guo · University Of California Los Angeles · R01 · FY2020 · AG
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells
$772,378Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R37 · FY2010 · HD
Structural Dynamics of Cardiac Muscle Calcium ATPase Regulation
$772,367David Dale Thomas · University Of Minnesota · R01 · FY2021 · HL
Defining modifiers and mechanisms of RAN translation
$771,846Joseph D Puglisi · Stanford University · R01 · FY2024 · AG
Efficacy and Mechanisms of a Metacognitive Strategy Intervention for Parkinson disease-related Cognitive Decline
$771,627Erin Foster · Washington University · R01 · FY2025 · AG
Peptide Biomarkers for Alzheimer Disease
$771,363Jing Zhang · University Of Washington · R01 · FY2017 · AG
Scalable, all-optical assays of synaptic function and plasticity
$771,167Graham Thomas Dempsey · Q-State Biosciences, Inc. · R44 · FY2020 · MH
Genetic characterization of atypical parkinsonism
$771,084Sonja Scholz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Assessing skin biomarkers for preclinical diagnosis of PD and non-PD Parkinsonism
$770,897Wen-Quan Zou · Case Western Reserve University · U01 · FY2019 · NS
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
$770,698Claudio Soto · University Of Texas Hlth Sci Ctr Houston · U24 · FY2024 · AG
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
$770,698Claudio Soto · University Of Texas Hlth Sci Ctr Houston · U24 · FY2025 · AG
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
$770,694Steven H Liang · Emory University · R61 · FY2024 · NS
Identification of Novel Small Molecules as Tau Protein Aggregation Inhibitors for
$770,675Alan D. Snow · Proteotech, Inc. · R43 · FY2011 · AG